Although numerous studies have demonstrated associations between traffic-related air pollution (TRAP) exposure and childhood allergic respiratory diseases, 1,2 few have investigated this association in adults. Most adult studies investigating associations between TRAP and allergic respiratory outcomes have been based on time series analyses assessing the effect of short-term exposure to higher levels of air pollution on acute exacerbations of asthma or asthma emergency department/hospital admissions. 3 Furthermore, little is known about regions with low levels of TRAP exposure (below the National Air Quality standards) and the risk of allergic respiratory diseases in adults. Recent reviews, based on a limited number of population studies investigating TRAP exposure and allergic respiratory diseases 4 and lung function in adults, have highlighted inconsistent results. 3, 4 These inconsistencies may be due to a range of factors, including differing genetic susceptibility to the effects of TRAP between study populations.
Air pollution-induced asthma has recently been identified as an important phenotype, although the mechanisms behind air 
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aOR: Adjusted odds ratio DEP: Diesel exhaust particle GSTs: Glutahione S-Transferaese genes GSTT1: Glutahione S-Transferaese theta1 GSTM1: Glutahione S-Transferaese mu1 GSTP1: Glutahione S-Transferaese pi1 HDM: House dust mite LUR: Land-use regression ROS: Reactive oxygen species TAHS: Tasmanian Longitudinal Health Study TRAP: Traffic-related air pollution pollution-induced asthma onset and exacerbations remain unclear. 5 TRAP exposure has been suggested to cause oxidative damage to the airways, leading to inflammation, remodeling, and increased risk of allergic sensitization. 4 Previous findings from both animal and in vitro experiments have shown that TRAP can enhance allergic reactions. 4, 6 Although allergic sensitization is known to be a strong risk factor for asthma, there is no consistent evidence that TRAP exposure is associated with allergic asthma.
The constituents of TRAP, including nitrogen dioxide (NO 2 ) and particulate matter, are strong oxidants. 7, 8 They cause oxidative stress in exposed individuals by producing reactive oxygen species (ROS). 5 Under ideal circumstances, ROS are buffered by the endogenous antioxidant system, 9 which includes enzymes produced by Glutathione S-Transferase genes (GSTs). Variants of the Glutathione S-Transferase pi1, mu1, and theta1 (GSTP1, GSTM1 and GSTT1, respectively) genes are of considerable interest, given that these genes code for phase II detoxification enzymes, which play an important role in modulating inflammatory responses and are triggered by ROS. 10 Previous studies, conducted predominantly in children, have demonstrated that carriers of the GSTM1 null variant and/or GSTP1 variant are at increased risk of allergic diseases when exposed to TRAP. 11 Very few studies in adults have reported on the interaction between polymorphisms in the GST genes and TRAP exposure on the risk of asthma, reduced lung function, and allergic sensitization. 11 We sought to quantify the association between current TRAP exposure and allergic sensitization, asthma, and lung function in adults using data from the Tasmanian Longitudinal Health Study (TAHS). We also aimed to determine whether these associations are modified by variants in the GSTT1, GSTM1, and GSTP1 genes.
METHODS

Study population
The study sample consisted of participants in TAHS. The design of this study has been previously described. 12 Subjects included in this analysis were adults who participated in the TAHS proband 2002 laboratory study. Briefly, TAHS started in 1968 by recruiting 8583 Tasmanian children aged 7 years. Participants of the baseline survey were known as ''probands.'' At the baseline survey, parents of the children completed a respiratory health questionnaire and probands underwent clinical examination and lung function measurements. Subsequent follow-up surveys were completed in 1974, 1981 , and 1992 at the ages of 13, 20, and 31 years, respectively. In 2002, when the probands were 44 years old, 7562 (88.1%) participants of the original 1968 cohort were invited to participate in a postal survey and responses were obtained for 5729 (78.4%) participants. 12 On the basis of participation in previous followups and history of asthma, a subgroup of participants (n 5 2387) was invited to undergo a detailed laboratory study, which was undertaken between 2005 and 2008. At the laboratory visit, participants underwent lung function tests and skin prick tests for allergens, and provided blood samples. In addition to laboratory tests, participants completed a detailed interviewer-administered questionnaire. Of the 2387 probands invited, 1405 (58.9%) participated in the laboratory study, while 1396 (58.9%) had valid skin prick test results (Fig 1) 
Exposure assessment
Address information was collected from all participants who attended the laboratory study (n 5 1405) and was successfully geocoded for 1367 (97.3%). The distance from participants' residences to the nearest major road was calculated in ArcGIS 10.1 (ArcGIS 10.1, Redlands, Calif: Environmental Systems Research Institute). Major roads were defined as public sector mapping agencies Australia transport hierarchy code 301 and 302 for the states of Victoria, Tasmania, Queensland, and New South Wales. Major roads included roads carrying ''massive traffic,'' categorized as freeways, highways, arterial roads, and subarterial roads. 13 Participants were classified as living in proximity to a major road if their residential address was less than 200 m in straight-line distance from a major road. This cutoff point was chosen on the basis of the known rate of decay observed in levels of major traffic pollutants downwind.
14 A satellite-based land-use regression (LUR) model was used to assign mean annual exposure to NO 2 . 15 Briefly, this LUR model used satellite observations of tropospheric NO 2 columns in combination with land use, roads, and other predictors to estimate ground-level NO 2 across Australia. The model captured 81% of the spatial variation in annual NO 2 levels between 2006 and 2011, with a cross-validated prediction error of 19%. 15 Mean annual residential exposures to outdoor NO 2 were estimated on the basis of participants' geocoded addresses. The selection of proximity roads and NO 2 as TRAP markers was based on previous findings showing a strong relationship of decaying NO 2 with increasing distance from major roads. 16 
Outcome definitions
Skin prick tests. Skin prick tests were performed for 8 aeroallergens -Dermatophagoides pteronyssinus, cat, Cladosporium cladosporioides, Alternaria tenuis, Penicillium mix, Aspergillus fumigatus, perennial ryegrass, and mixed grasses (which included Kentucky bluegrass, orchard, redtop, timothy, sweet vernal grass, and meadow fescue) (Hollister-Stier, Spokane, Wash)-using histamine as a positive control and a standard technique. 17 A wheal size of 3 mm or more than that with the negative control was regarded as an indication of sensitization. Sensitization was categorized into atopy (sensitized to any of the aeroallergens tested, eg, Dermatophagoides pteronyssinus, cat, Cladosporium cladosporioides, Alternaria tenuis, Penicillium mix, Aspergillus fumigatus, perennial ryegrass, and mixed grasses) and sensitization to any mold allergens tested (eg, Cladosporium cladosporioides, Alternaria tenuis, Penicillium mix, and Aspergillus fumigatus).
Lung function tests. Spirometry was performed using the EasyOne
Ultrasonic Spirometer (Ndd, Medizintechnik, AG, Switzerland). Detailed methods have been published elsewhere. 18 Briefly, spirometry was conducted according to the joint American Thoracic Society and European Respiratory Society guidelines. 19 Spirometry was repeated 10 minutes after 200 mg of salbutamol was administered via a spacer. Reference values from the Global Lung Initiative 2012 were used to derive z scores. 20 Z scores describe the deviation from the mean predicted value and are expressed as SDs.
Asthma definition
Current asthma was defined as having asthma or wheezy breathing within the last year. Current atopic asthma was defined as asthma or wheezy breathing within the last year and sensitization to any allergen tested. Current nonatopic asthma was defined as asthma or wheezy breathing within the last year J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 1 and not sensitized to any allergen tested. Current wheeze was defined as wheezing or whistling in the chest without having a cold, in the last 12 months.
Genetic data
Blood samples for genetic analysis were collected at the laboratory study. Genotyping of GSTM1 and GSTT1 was performed using a multiplex PCR technique, 21 and for all experiments positive primers for beta-globin were included as a positive PCR control. Individuals were classified as either GSTT1 null (homozygous for the GSTT1*0 allele) or GSTT1 non-null (homozygous or heterozygous for the GSTT1*1 allele) and as either GSTM1 null (homozygous for the GSTM1*0 allele) or GSTM1 non-null (possessing at least 1 functional GSTM1 allele). A customized Illumina GoldenGate Genotyping Assay (www.illumina.com) was used to genotype the GSTP1 (rs1695 A/G: Ile105Val) polymorphism. Individuals were categorized as having GSTP1-AA, GSTP1-AG, or GSTP1-GG genotype.
Statistical analysis
The associations of both NO 2 exposure and proximity to major roads with the outcomes of allergic sensitization, asthma, and wheeze were assessed using logistic regression models. The association between the exposure variables and lung function (FEV 1 , forced vital capacity, FEV 1 /forced vital capacity, and forced expiratory flow at 25% to 75% of forced vital capacity) was analyzed using linear regression models. The lung function test results are normally distributed. Hence, regression with no transformation of the lung function tests has been performed. Covariates were selected for the models after considering alternative causal models using a directed acyclic graph in DAGitty software. 22 Socioeconomic status (defined using education), smoking status, gas cooking, gas heating, keeping windows open more than 1 hour per week, and rural or urban status (using Accessibility/Remoteness Index of Australia 2006) were included in the regression models. In all models, NO 2 exposure was entered as a continuous variable, while living less than 200 m from a major road was treated as a dichotomous exposure.
Initially, associations were examined between the exposure variables and allergic sensitization, asthma, wheeze, and lung function. To investigate the potential effect modification role by genetic polymorphisms, categorical variables of GST genotypes were then added as an interaction term to the regression models. For all 3 genes, an autosomal-dominant genetic model was assumed, with genotypes entered as binary variables. For interactions, P < _.10 was considered as significant and stratified analyses were subsequently performed. All associations were assessed by including the same confounders that were identified in the initial directed acyclic graph. STATA version 13.1 (Stata Corporation, College Station, Tex) was used to perform all the statistical analyses. Results for NO 2 exposure were scaled to an interquartile range increase in mean annual NO 2 , which in this sample was 2.2 ppb.
RESULTS
The mean age of the cohort at participation was 44.8 6 1 years and 49% were men (Table I) . More than half (55.8%) of the cohort was sensitized to at least 1 of the aeroallergens tested. Sensitization to house dust mite (HDM) was the most prevalent type of allergic sensitization (41.3%), followed by perennial rye grass (32.0%) and mixed grasses (30.7%). The prevalence of current asthma and wheeze was 23.6% and 28.5%, respectively. Study characteristics of the participants without a geocoded residential address (2.7%) were similar to those of participants who had a geocoded residential address, other than slight difference in sex (male sex 5 63%) (data not shown).
Of all participants, 27.4% lived less than 200 m from a major road (Table I ). The mean annual NO 2 exposure of the cohort was 5.1 6 2.6 ppb. The correlation between distance to major roads and mean annual NO 2 at the home address was modest (r 5 20.40). More than half of the participants had at least 1 val allele in GSTP1 (60.10%), while 16.15% had a null allele in GSTT1 (Table I) .
Main environmental effects
Each IQR increase in mean annual NO 2 exposure (2.2 ppb) was associated with increased risk of atopy (adjusted odds ratio [aOR]), 1.14; 95% CI, 1.02-1.28) and cat (aOR, 1.31; 95% CI, 1.15-1.49) and HDM sensitization (aOR, 1.20; 95% CI, 1.08-1.34). Similarly, there was a significant association between living less than 200 m from a major road and HDM sensitization (aOR, 1.33; 95% CI, 1.04-1.70), and a trend toward a significant association between living less than 200 m from a major road and atopy (aOR, 1.26; 95% CI, 0.99-1.62) (Tables II and III) . Mean annual NO 2 exposure was associated with atopic asthma (aOR, 1.14; 95% CI, 1.00-1.30), but not with nonatopic asthma. Both measures of exposure variables were associated with an increased risk of wheeze (NO 2 aOR, 1.14; 95% CI, 1.02-1.28; <200 m aOR, 1.38; 95% CI, 1.06-1.80) (Tables II and III) .
Living less than 200 m from a major road was associated with a significant reduction in both prebronchodilator and postbronchodilator FEV 1 and prebronchodilator forced expiratory flow at 25% to 75% of forced vital capacity (b, 20.14; 95% CI, 20.28 to 20.01; b, 20.13; 95% CI, 20.26 to 0.00 and b, 20.14; 95% CI, 20.27 to 20.01, respectively). Similar but nonsignificant trends were observed between NO 2 exposure and the same lung function outcomes (Tables II and III ). The ratio FEV 1 /forced vital capacity was not associated with either TRAP exposure.
Main genetic effects
Gene variants in GSTT1, GSTM1, or GSTP1 were not associated with sensitization, respiratory outcomes, or lung function except for 1 isolated finding (see Table E1 in this article's Online Repository at www.jacionline.org), where carriers of GSTM1 null had a reduced risk of cat allergen sensitization (aOR, 0.70; 95% CI, 0.51-0.97).
Interactions with GSTT1, GSTM1, and GSTP1
We examined whether there was any interaction between the GST polymorphisms and air pollution exposure assessed using either living less than 200 m from a major road or NO 2 levels, and the results are presented in Table IV . There were significant interactions between GSTT1 polymorphism and living less than 200 m from a major road for several outcomes including atopy, HDM sensitization, current wheeze, current asthma, and current atopic asthma. For all outcomes, there was a greater risk for carriers of the GSTT1 null. There was also a trend toward significant interactions between GSTT1 polymorphism and NO 2 levels for atopy, cat sensitization, and HDM sensitization. For these outcomes, there were significantly increased risks in both the GSTT1 null and non-null groups with increasing exposure to NO 2 . However, the odds ratios were higher in those with the GSTT1 null. No significant interaction between either GSTM1 or GSTP1 and either of the air pollution exposure measures was observed for any allergic sensitization or respiratory outcomes. No significant interaction between any of the GST polymorphisms and either of the air pollution exposure measure was observed for any of the lung function outcomes.
DISCUSSION
Our study provides evidence that current TRAP exposure is associated with an increased risk of allergic sensitization, asthma, and wheeze, and some measures of lung function in adults. The majority of our findings are consistent for both the measures related to TRAP exposure we assessed: annual mean NO 2 estimated by a satellite-based LUR model and living less than 200 m from a major road. The mean annual NO 2 exposure in our study is very low compared with that in other TRAP exposure studies, which have been conducted only in Europe and North America. 2 Nevertheless, even at very low concentrations of TRAP exposure, we observed associations with allergic airway disease. Polymorphisms in GSTT1 modified the associations between TRAP exposure and atopy, and these polymorphisms also modified the associations between distance to major roads and allergic airway disease. Only 4 previous studies have investigated associations between TRAP exposure and adult allergic sensitization, all of which were conducted in Europe and North America. [23] [24] [25] [26] Only 2 of these reported an increased risk of allergic sensitization associated with exposure to high traffic counts 25 and/or living less than 50 m from a major road. 26 Exposure misclassification may have attenuated effects and contributed to the null findings in the remaining 2 studies, as one used self-reported traffic intensity 24 and the other used data derived from a central monitoring station. 23 None of these studies looked at interactions with GSTs.
Australia is a country with low levels of air pollution 3 and in our study the mean annual residential NO 2 level was 5.16 2.6 ppb, which was substantially lower than the National Air Quality standard (mean annual NO 2 5 30 ppb). Nevertheless, we were able to demonstrate that even low levels of TRAP are associated with allergic respiratory diseases.
The evidence from human and animal studies supports our findings of an association between current air pollution exposure and current allergic sensitization. Both animal and human challenge studies have found that the immune responses to new antigens in the presence of diesel exhaust particles (DEPs) are altered toward an IgE response rather than an IgG response. 27 In addition, in mice, coexposures to HDM and DEPs promote a mixed T H 2/T H 17 response, resulting in increased severity of allergic asthma. 5 As with mice models, when humans sensitized Reference group for nonatopic and atopic asthma is never asthma. àValues are expressed as the mean (SD) unless otherwise specified (A z score is the deviation from the mean predicted value, where 95% of normally distributed data lie between -1.96 SD and 11.96 SD).
to ragweed are exposed to DEPs and ragweed, a higher ragweedspecific IgE level and a skewed T H 2 response have been observed. 28 Furthermore, when humans are exposed to components of TRAP such as polycyclic aromatic hydrocarbons and DEPs, there is a suppression of regulatory T-cell function, leading to exacerbation of asthma. 29, 30 In addition, in human subjects polycyclic aromatic hydrocarbons have been shown to produce epigenetic changes resulting in suppression of Treg-cell function and a shifting toward T H 2 responses. 4, 29 Variants of the GSTs that are linked with decreased oxidative capacity have been reported by both epidemiological and controlled human exposure studies to modify the association with TRAP-induced allergic diseases. 11, 31 Variants in GSTM1 and GSTT1 are characterized by the presence or absence of a BD, Bronchodilator; FEF 25%-75% , forced expiratory flow at 25% to 75% of forced vital capacity; FVC, forced vital capacity; OR, odds ratio. *Adjusted for socioeconomic status, smoking status, rural/urban location, gas cooking, gas heating, and open windows >1 h/wk. Reference group for nonatopic and atopic asthma is never asthma. àValues are expressed as the mean (SD) unless otherwise specified (A z score is the deviation from the mean predicted value, where 95% of normally distributed data lie between -1.96 SD and 11.96 SD).
TABLE IV. Stratified analysis of GSTT1 interactions for outcomes with an interaction P value of < _.10 (for the associations between exposure to mean annual NO 2 and living <200 m from a major road and outcomes of allergic sensitization and respiratory outcomes, results of interactions P value > .10 not shown) homozygous allele deletion, known as null genotype. GSTT1, GSTM1, and GSTP1 act through a common mechanism involved in managing oxidative stress, where conjugating ROS with glutathione enables detoxification and ultimately protects tissues against oxidative damage. 32 Past literature has shown effect modification by GSTs of the effect of TRAP exposure on allergic disease outcomes. 33, 34 However, very few studies have investigated the effect modification by GSTs on the association between TRAP exposure and allergic sensitization. 35, 36 All these studies have focused on children and have investigated interactions only with GSTP1 variants. 35, 36 Our study is the first to demonstrate effect modification by GSTs on the association between TRAP exposure and allergic sensitization in adults.
There is evidence of interaction between GSTT1 and some environmental pollutants in asthma and airway obstruction. A study of children aged between 9 and 11 years reported environmental tobacco smoke exposure to be associated with prevalence of current asthma and wheeze, but only for children with GSTT1 null deletion. 37 The few studies that examined the effect of interactions between GSTT1 variants and TRAP exposure on asthma/ lung function found no evidence. 11, 38 We found that GSTT1 null carriers had a higher risk of atopy than did carriers of GSTT1 nonnull when living less than 200 m from a major road and exposure to increased NO 2 . GSTT1 null carriers when lived less than 200 m from a major road had increased current wheeze, asthma, and atopic asthma, but not with NO 2 exposure. Similar to our results, a study investigating the interaction of GSTT1 with the association of NO 2 exposure and asthma in adults found no significant effect. 38 Another study investigating the interaction of GSTT1 with the association of particulate matter exposure and peak expiratory flow in children found no significant interaction 39 but its limited sample size (n 5 43) may have precluded its ability to detect such associations. In support of our findings, a recent controlled human experimental study reported augmented allergeninduced allergic airway inflammation and IL-5 response when exposed to DEPs for a short period of time. These effects were enhanced in individuals carrying GSTT1 null genotype, 40 supporting the hypothesis that TRAP exposure may exacerbate inflammation in genetically susceptible individuals with existing allergic conditions. Our study has strengths and limitations. It is a cross-sectional analysis nested within a well-characterized cohort. The cohort has been well characterized with objective measures of allergy and lung function. Although frequently followed up, TRAP exposure from previous follow-ups could not be evaluated because of lack of exposure and address data, so we were unable to assess longitudinal effects on respiratory and allergic outcomes. This article investigated only whether current TRAP exposure was related to current allergic sensitization, asthma, wheeze, and lung function, but not whether TRAP exposure has initiated these conditions. Therefore, we cannot draw any conclusions on the role of TRAP in allergic etiology of these outcomes. However, our results demonstrate that current TRAP exposures may well exacerbate existing disease conditions. We used modeled NO 2 exposure from a national LUR model that allowed us to use a single model for all participants regardless of location and which has been found to predict annual NO 2 exposure with relatively low error of 19%. 15 We cannot ascribe our findings to NO 2 specifically, because it is only a single proxy for the complex pollutant mixtures that characterize TRAP. Limitations of the proximity variable used in our study have been previously discussed, such as not considering wind directions, traffic volume, and composition. 41 The predictive ability of the NO 2 model in urban areas may be better than in rural or remote areas where the resolution and variability in predictor variables are greater. 15 This could introduce exposure misclassification. However, the consistency between the results for NO 2 and living less than 200 m from a major road suggest that both are good surrogates for TRAP exposure. 16 In the present study, we did not correct for multiple comparisons and it is possible that at least some of the observed associations are due to type 1 error. However, we have examined only presuggested and biologically plausible hypotheses, and our selection of genes was based on previously reported strong associations. It is possible that we have not detected some gene and TRAP interactions because of limited power given the sample size of our study. Therefore, we highlight the overall pattern of results related to interactions, rather than individual significant associations, as evidence for modification of the association between TRAP exposure and the relevant outcomes by the GST gene polymorphisms.
In conclusion, TRAP exposure during middle age, even at relatively low levels of exposure, is associated with increased risk of allergic sensitization, asthma, and lower levels of lung function. Carriers of GSTT1 null may be at a greater risk for these outcomes. These findings have important public health implications, particularly for individuals who are genetically susceptible. Current air quality standards in Australia may not fully protect the population. In addition, further studies should be carried out to help elucidate the biological mechanisms underpinning the relationship between GST polymorphisms, TRAP exposure, and allergic sensitization. 
